[Statin therapy does not influence in the form onset of differentiated thyroid carcinoma].
Servicio de Endocrinología y Nutrición, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, España. Electronic address: 26276czl@comb.cat.
Carles
C
Zafon
Servicio de Endocrinología y Nutrición, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, España.
Gabriel
G
Obiols
Servicio de Endocrinología y Nutrición, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, España.
Jordi
J
Mesa
D018263:Adenocarcinoma, Follicular / Q000453:epidemiology / Q000473:pathology*; D000368:Aged; D002291:Carcinoma, Papillary / Q000453:epidemiology / Q000473:pathology*; D002454:Cell Differentiation; D015897:Comorbidity; D003924:Diabetes Mellitus, Type 2 / Q000453:epidemiology; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D013961:Thyroid Gland / Q000187:drug effects* / Q000473:pathology; D013964:Thyroid Neoplasms / Q000453:epidemiology / Q000473:pathology*; D013966:Thyroiditis / Q000453:epidemiology; D013972:Thyrotropin / Q000097:blood; D047368:Tumor Burden
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D013972:Thyrotropin